Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $469.9800 (-2.73%) ($466.9350 - $469.9800) on Wed. Jan. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.74% (three month average) | RSI | 36 | Latest Price | $469.9800(-2.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.6% a day on average for past five trading days. | Weekly Trend | REGN declines -1.5% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(43%) SPLV(37%) DIA(36%) IVW(36%) | Factors Impacting REGN price | REGN will decline at least -0.87% in a week (0% probabilities). VIXM(-21%) TBT(-7%) IGOV(-7%) VXX(-6%) UUP(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.87% (StdDev 1.74%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $487.29 | 5 Day Moving Average | $479.33(-1.95%) | 10 Day Moving Average | $483.2(-2.74%) | 20 Day Moving Average | $487.29(-3.55%) | To recent high | -22.7% | To recent low | 0% | Market Cap | $49.831b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |